To assess whether the DIABELOOP algorithm provides better glycemic control than the usual algorithm of T1D patients on pump therapy: * at meals, with CHO roughly assessed by the patient. * during and after physical activity sessions qualified as moderate by the patient. Primary endpoint : time within the glycemic reference range. The study will be conduct with 15 patients at the following investigation centers : Corbeil Hospital, CHU of Grenoble, and CHU of Montpellier.
The 15 patients will have 2 visits during 24 hours (day and night), once with their usual algorithm and once with the Diabeloop system.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
17
the insulin dose is calculated by the "Diabeloop" algorithm and then administered to the patient
Centre Hospitalier du Sud Francillien
Évry, France
University Hospital of Grenoble
Grenoble, France
University Hospital of Montpellier
Montpellier, France
Time spent in blood glucose range [70-180 mg/dl]
comparing the time spent in \[70-180 mg/dl\] with usual algorithm vs Diabeloop algorithm.
Time frame: up to 24 hours after each treatment period
Time spent Blood Glucose range [80-140 mg/dl]
Comparing the time spent in range \[80-140 mg/dl\] with usual algorithm vs Diabeloop algorithm
Time frame: 24 hours after each treatment period
time spent below 70 mg/dl and above 180 mg/dl
Time frame: up to 24 hours after each treatment period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.